Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.40 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.36 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.36 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.36 |
| ▸ | GHSR | Q92847 | 3/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.35 |
| ▸ | CDK2 | P24941 | 2/20 | 0.35 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30834755 | 0.97 | SLC15A2 (0.44) | SLC15A2ERAP2LNPEPERAP1GHSR | |
| SCHEMBL30945038 | 0.94 | SLC15A2 (0.35) | SLC15A2GHSR | |
| SCHEMBL31453808 | 0.90 | SLC15A2 (0.47) | SLC15A2ERAP2LNPEPGHSR | |
| SCHEMBL1071387 | 0.90 | SLC15A2 (0.48) | SLC15A2ERAP2LNPEPERAP1GHSR | |
| SCHEMBL1071384 | 0.90 | SLC15A2 (0.48) | SLC15A2ERAP2LNPEPERAP1GHSR | |
| SCHEMBL29973895 | 0.89 | PSMB1 (0.35) | — | |
| SCHEMBL31181290 | 0.89 | GHSR (0.47) | GHSR | |
| SCHEMBL29398799 | 0.89 | CCNA2 (0.44) | SLC15A2ERAP2LNPEPERAP1GHSR | |
| SCHEMBL31188427 | 0.89 | SLC15A2 (0.40) | SLC15A2ERAP2LNPEPERAP1GHSR | |
| SCHEMBL30618482 | 0.89 | SLC15A2 (0.42) | SLC15A2GHSRCCNA2CDK2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12594227-B2 | Tetrapeptide and compositions comprising tetrapeptides | THE BOOTS COMPANY PLC (GB) | 2026-04-07 | — | — | US | disclosed |
| WO-2026046854-A1 | PEPTIDE CONTAINING HYDROGEL COMPOSITIONS | THE BOOTS COMPANY PLC (GB) | 2026-03-05 | — | — | WO | disclosed |
| WO-2025215348-A1 | SKIN WOUND TREATMENT | THE BOOTS COMPANY PLC (GB) | 2025-10-16 | — | — | WO | disclosed |
| WO-2025215349-A1 | HAIR GROWTH RESTORATION | THE BOOTS COMPANY PLC (GB) | 2025-10-16 | — | — | WO | disclosed |
| EP-4631517-A1 | SKIN WOUND TREATMENT | The Boots Company plc (GB) | 2025-10-15 | — | — | EP | disclosed |
| EP-4631518-A1 | COMPOSITIONS FOR TREATING DISEASES OF THE AIRWAYS | The Boots Company plc (GB) | 2025-10-15 | — | — | EP | disclosed |
| US-20250170043-A1 | KIT OF COSMETIC COMPOSITIONS | THE BOOTS COMPANY PLC (GB) | 2025-05-29 | — | — | US | disclosed |
| US-20250161201-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | disclosed |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-15 | — | — | US | disclosed |
| US-20250054582-A1 | METHOD OF IDENTIFYING A SOLVENT FOR A MATRIKINE | THE BOOTS COMPANY PLC (GB) | 2025-02-13 | — | — | US | disclosed |
| EP-4140471-A1 | COMPOSITION WITH BIOLOGICALLY ACTIVE AGENT | The Boots Company plc (GB) | 2023-03-01 | — | — | EP | disclosed |
| WO-2022106054-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | THE BOOTS COMPANY PLC (GB) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022106055-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | THE BOOTS COMPANY PLC (GB) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022106057-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | THE BOOTS COMPANY PLC (GB) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022106056-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | THE BOOTS COMPANY PLC (GB) | 2022-05-27 | — | — | WO | disclosed |
| EP-4000598-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | The Boots Company plc (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-4001294-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | The Boots Company plc (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-4000597-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | The Boots Company plc (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-4000595-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | The Boots Company plc (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-4000596-A1 | TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES | The Boots Company plc (GB) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12594227-B2 | Tetrapeptide and compositions comprising tetrapeptides | SRRM2, SGTA, QARS1 | SLC15A2 775/4885ERAP2 1563/4885LNPEP 1524/4885 |
| US-20250170043-A1 | KIT OF COSMETIC COMPOSITIONS | CHKA, CHKB, SGMS2 | SLC15A2 3889/4885ERAP2 1992/4885LNPEP 2924/4885 |
| US-20250161201-A1 | COSMETIC COMPOSITION | CYP19A1, SHBG, HSD17B11 | SLC15A2 4269/4885ERAP2 1584/4885LNPEP 2026/4885 |
| US-20250152494-A1 | COSMETIC COMPOSITION CONTAINING RETINOID, EXTRACT OF CENTELLA ASIATICA AND A DIPEPTIDE | RARA, RARG, RARB | SLC15A2 2929/4885ERAP2 459/4885LNPEP 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.